108 related articles for article (PubMed ID: 23531664)
21. [Microcirculation end effect of detralex in patients with chronic venous insufficiency of the lower extremities].
Sirotin BZ; Zhmerenetskĭ KV
Angiol Sosud Khir; 2003; 9(3):60-5. PubMed ID: 14657934
[TBL] [Abstract][Full Text] [Related]
22. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
[TBL] [Abstract][Full Text] [Related]
23. Elevated cutaneous leukocyte concentration in a rodent model of acute venous hypertension.
Lalka SG; Unthank JL; Nixon JC
J Surg Res; 1998 Jan; 74(1):59-63. PubMed ID: 9536975
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic aspects of a phlebotropic drug in CVI-associated edema.
Ramelet AA
Angiology; 2000 Jan; 51(1):19-23. PubMed ID: 10667639
[TBL] [Abstract][Full Text] [Related]
25. A review of evidence on red vine leaf extract in the prevention and management of venous disease.
Butcher M
J Wound Care; 2006 Oct; 15(9):393-6. PubMed ID: 17044354
[No Abstract] [Full Text] [Related]
26. [The microcirculatory activity of Centella asiatica in venous insufficiency. A double-blind study].
Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Grimaldi R; Marelli C; Belcaro G
Minerva Cardioangiol; 1994 Jun; 42(6):299-304. PubMed ID: 7936334
[TBL] [Abstract][Full Text] [Related]
27. [Bioflavonoids and their significance in angiology: focus on diosmin].
Bogachev VIu; Golovanova OV; Kuznetsov AN; Shekoian AO
Angiol Sosud Khir; 2013; 19(1):73-81. PubMed ID: 23531663
[TBL] [Abstract][Full Text] [Related]
28. Improvement of microcirculation and healing of venous hypertension and ulcers with Crystacide: evaluation with a microcirculatory model, including free radicals, laser doppler flux, and PO2/PCO2 measurements.
Belcaro G; Cesarone MR; Errichi BM; Di Renzo A; Errichi S; Ricci A; Gizzi G; Dugall M; Cacchio M; Ruffini I; Fano F; Vinciguerra G; Grossi MG
Angiology; 2007; 58(3):323-8. PubMed ID: 17626987
[TBL] [Abstract][Full Text] [Related]
29. [Methods of operative interventions in postthrombotic disease of the crus].
Sultanov DD; Azizov AA; Kamolov AN
Angiol Sosud Khir; 2011; 17(2):89-93. PubMed ID: 21983465
[TBL] [Abstract][Full Text] [Related]
30. Control of therapy with microcirculatory and phlebotropically active drugs in patients with congenital and acquired venous insufficiency.
Wenzel E; Birkel L; Scheffler P; Waldhausen P; Jung F
Int Angiol; 1989; 8(1):41-6. PubMed ID: 2549130
[TBL] [Abstract][Full Text] [Related]
31. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI).
Franzeck UK; Haselbach P; Speiser D; Bollinger A
Yale J Biol Med; 1993; 66(1):37-46. PubMed ID: 8256463
[TBL] [Abstract][Full Text] [Related]
32. The importance of deep venous reflux velocity as a determinant of outcome in patients with combined superficial and deep venous reflux treated with endovenous saphenous ablation.
Marston WA; Brabham VW; Mendes R; Berndt D; Weiner M; Keagy B
J Vasc Surg; 2008 Aug; 48(2):400-5; discussion 405-6. PubMed ID: 18644484
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
Andreozzi GM
Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
[TBL] [Abstract][Full Text] [Related]
34. [Chronic venous insufficiency].
Veraart JC
Ned Tijdschr Geneeskd; 2002 Feb; 146(5):199-203. PubMed ID: 11851078
[TBL] [Abstract][Full Text] [Related]
35. [Current aspects of endothelial protection in treatment of patients with chronic venous insufficiency at the stage of trophic disorders].
Stoiko YM; Gudymovich VG; Tsyplyashchuk AV
Angiol Sosud Khir; 2016; 22(4):109-114. PubMed ID: 27935889
[TBL] [Abstract][Full Text] [Related]
36. Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study.
Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Ippolito E; Fano F; Dugall M; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
Phytomedicine; 2010 Sep; 17(11):835-9. PubMed ID: 20579863
[TBL] [Abstract][Full Text] [Related]
37. [The use of Ginkor Fort in the program of multimodality rehabilitation treatment of CYI patients with edematous syndrome].
Liadov KV; Stoĭko IuM; Gudymovich VG; Sokolov AL
Angiol Sosud Khir; 2005; 11(4):91-8. PubMed ID: 16474295
[TBL] [Abstract][Full Text] [Related]
38. [The use of antistax in the treatment of discirculatory encephalopathy].
Rzheusskaia GV; Listopadov IuI; Kireenkov IS; Kitaeva EA; Makarova NV; Eremina NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):60-3. PubMed ID: 21183907
[TBL] [Abstract][Full Text] [Related]
39. Oedema protective properties of the red vine leaf extract AS 195 (Folia vitis viniferae) in the treatment of chronic venous insufficiency. A 6-week observational clinical trial.
Schaefer E; Peil H; Ambrosetti L; Petrini O
Arzneimittelforschung; 2003; 53(4):243-6. PubMed ID: 12785119
[TBL] [Abstract][Full Text] [Related]
40. Regulation of adhesion molecules: a new target for the treatment of chronic venous insufficiency.
Verbeuren TJ; Bouskela E; Cohen RA; Vanhoutte PM
Microcirculation; 2000; 7(6 Pt 2):S41-8. PubMed ID: 11151971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
